A phase 1/2, open‐label, dose‐escalation study of midostaurin in children with relapsed or refractory acute leukaemia. (11th September 2018) - Zwaan, C. Michel; Söderhäll, Stefan; Brethon, Benoit; Luciani, Matteo; Rizzari, Carmelo; Stam, Ronald W.; Besse, Emmanuelle; Dutreix, Catherine; Fagioli, Franca; Ho, Phoenix A.; Dufour, Carlo; Pieters, Rob